SPARC promotes the development of erythroid progenitors

Experimental Hematology

Volumn 40, Issue 10, 2012, Pages 828-836

  Luo, Zhen ^a   Luo, Pan ^a   Yu, Yan ^a   Zhao, Qian ^a   Zhao, Xiuhua ^a   Cheng, Lamei ^a,b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b National Engineering and Research Center of Human Stem Cells   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD71 ANTIGEN; GLYCOPHORIN A; HEMOGLOBIN; OSTEONECTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLOOD; BONE MARROW; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; BURST FORMING UNIT; CELL CULTURE; CELL DIFFERENTIATION; COLONY FORMING CELL; COLONY FORMING UNIT; CONTROLLED STUDY; ERYTHROCYTE COUNT; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; FLOW CYTOMETRY; HEMOGLOBIN BLOOD LEVEL; IN VITRO STUDY; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; UMBILICAL CORD BLOOD; WILD TYPE;

ANIMALS; ANTIGENS, CD; BONE MARROW TRANSPLANTATION; CELL DIFFERENTIATION; CELLS, CULTURED; COLONY-FORMING UNITS ASSAY; ERYTHROID PRECURSOR CELLS; ERYTHROPOIESIS; FETAL BLOOD; GLYCOPHORIN; HUMANS; MICE; MICE, KNOCKOUT; OSTEONECTIN; RECEPTORS, TRANSFERRIN;

MUS;

EID: 84866338415     PISSN: 0301472X     EISSN: 18732399     Source Type: Journal    
DOI: 10.1016/j.exphem.2012.06.002     Document Type: Article

References (27)

1. Westwood N.B., Chung R., Emmerson A.J., Pearson T.C. The in vitro effects of stem cell factor, interleukin 3 and granulocyte-macrophage colony stimulating factor on haemopoietic progenitor cells from premature infants. Br J Haematol 1994, 86:468-474.
2. Wu H., Klingmuller U., Besmer P., Lodish H.F. Interaction of the erythropoietin and stem-cell-factor receptors. Nature 1995, 377:242-246.
3. Zermati Y., Fichelson S., Valensi F., et al. Transforming growth factor inhibits erythropoiesis by blocking proliferation and accelerating differentiation of erythroid progenitors. Exp Hematol 2000, 28:885-894.
4. Toretsky J.A., Shahidi N.T., Finlay J.L. Effects of recombinant human interferon gamma on hematopoietic progenitor cell growth. Exp Hematol 1986, 14:182-186.
5. Akahane K., Hosoi T., Urabe A., Kawakami M., Takaku F. Effects of recombinant human tumor necrosis factor (rhTNF) on normal human and mouse hemopoietic progenitor cells. Int J Cell Cloning 1987, 5:16-26.
6. Xiao W., Koizumi K., Nishio M., et al. Tumor necrosis factor-alpha inhibits generation of glycophorin A+ cells by CD34+ cells. Exp Hematol 2002, 30:1238-1247.
7. Yan Q., Sage E.H. SPARC, a matricellular glycoprotein with important biological functions. J Histochem Cytochem 1999, 47:1495-1506.
8. Kupprion C., Motamed K., Sage E.H. SPARC (BM-40, osteonectin) inhibits the mitogenic effect of vascular endothelial growth factor on microvascular endothelial cells. J Biol Chem 1998, 273:29635-29640.
9. Raines E.W., Lane T.F., Iruela-Arispe M.L., Ross R., Sage E.H. The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors. Proc Natl Acad Sci U S A 1992, 89:1281-1285.
10. Brekken R.A., Sage E.H. SPARC, a matricellular protein: at the crossroads of cell-matrix communication. Matrix Biol 2001, 19:816-827.
11. Oritani K., Kincade P.W. Identification of stromal cell products that interact with pre-B cells. J Cell Biol 1996, 134:771-782.
12. Rempel S.A., Hawley R.C., Gutierrez J.A., et al. Splenic and immune alterations of the Sparc-null mouse accompany a lack of immune response. Genes Immun 2007, 8:262-274.
13. Lehmann S., O'Kelly J., Raynaud S., Funk S.E., Sage E.H., Koeffler H.P. Common deleted genes in the 5q- syndrome: thrombocytopenia and reduced erythroid colony formation in SPARC null mice. Leukemia 2007, 21:1931-1936.
14. Peters S.O., Bauermeister K., Simon J.P., Branke B., Wagner T. Quantitative polymerase chain reaction-based assay with fluorogenic Y-chromosome specific probes to measure bone marrow chimerism in mice. J Immunol Methods 2002, 260:109-116.
15. Nilsson S.K., Johnston H.M., Coverdale J.A. Spatial localization of transplanted hemopoietic stem cells: inferences for the localization of stem cell niches. Blood 2001, 97:2293-2299.
16. Hexner E.O., Serdikoff C., Jan M., et al. Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders. Blood 2008, 111:5663-5671.
17. Siva K., Jaako P., Miharada K., et al. SPARC is dispensable for murine hematopoiesis, despite its suspected pathophysiological role in 5q- myelodysplastic syndrome. Leukemia 2012 Apr 5, [Epub ahead of print]. 10.1038/leu.2012.97.
18. Gilmour D.T., Lyon G.J., Carlton M.B., et al. Mice deficient for the secreted glycoprotein SPARC/osteonectin/BM40 develop normally but show severe age-onset cataract formation and disruption of the lens. EMBO J 1998, 17:1860-1870.
19. Na Nakorn T., Traver D., Weissman I.L., Akashi K. Myeloerythroid-restricted progenitors are sufficient to confer radioprotection and provide the majority of day 8 CFU-S. J Clin Invest 2002, 109:1579-1585.
20. Kina T., Ikuta K., Takayama E., et al. The monoclonal antibody TER-119 recognizes a molecule associated with glycophorin A and specifically marks the late stages of murine erythroid lineage. Br J Haematol 2000, 109:280-287.
21. Yiu G.K., Chan W.Y., Ng S.W., et al. SPARC (secreted protein acidic and rich in cysteine) induces apoptosis in ovarian cancer cells. Am J Pathol 2001, 159:609-622.
22. Fenouille N., Puissant A., Tichet M., et al. SPARC functions as an anti-stress factor by inactivating p53 through Akt-mediated MDM2 phosphorylation to promote melanoma cell survival. Oncogene 2011, 30:4887-4900.
23. Flygare J., Rayon Estrada V., Shin C., Gupta S., Lodish H.F. HIF1alpha synergizes with glucocorticoids to promote BFU-E progenitor self-renewal. Blood 2011, 117:3435-3444.
24. Wen J., Huang S., Rogers H., Dickinson L.A., Kohwi-Shigematsu T., Noguchi C.T. SATB1 family protein expressed during early erythroid differentiation modifies globin gene expression. Blood 2005, 105:3330-3339.
25. Li K., Cai R., Dai B.B., et al. SATB1 regulates SPARC expression in K562 cell line through binding to a specific sequence in the third intron. Biochem Biophys Res Commun 2007, 356:6-12.
26. Tanaka R., Owaki T., Kamiya S., et al. VLA-5-mediated adhesion to fibronectin accelerates hemin-stimulated erythroid differentiation of K562 cells through induction of VLA-4 expression. J Biol Chem 2009, 284:19817-19825.
27. Nie J., Chang B., Traktuev D.O., et al. IFATS collection: Combinatorial peptides identify alpha5beta1 integrin as a receptor for the matricellular protein SPARC on adipose stromal cells. Stem Cells 2008, 26:2735-2745.